Insights from the REVEAL Registry. Patients with PCWP 16 to 18 mm Hg who were diagnosed and treated for PAH were older, heavier, and more likely to have comorbidities associated with left ventricular diastolic dysfunction. Five-year survival rates were similarly low for all PCWP subgroups. CHEST,January 2013, Vol 143, No. 1 (Also see: Pulmonary Hypertension Prognosis and REVEAL Registry)
This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.